All Publications Citing Use of MCE Products

• J Adv Res. 2024 Apr 14:S2090-1232(24)00155-3. Erastin, Nile Red, Ferrostatin-1, RS102895 hydrochloride, Metformin purchased from MCE.

• J Exp Clin Cancer Res. 2024 Jun 20;43(1):173. MG-132, Bafilomycin A1, Tamoxifen purchased from MCE.

• J Exp Clin Cancer Res. 2024 May 30;43(1):152. Trichostatin A, Brepocitinib, GSK-J1, Decitabine purchased from MCE.

• J Exp Clin Cancer Res. 2024 Jun 18;43(1):171. Trametinib, MSP/MST1 Protein, Mouse (C677A, HEK293) purchased from MCE.

• J Exp Clin Cancer Res. 2024 May 11;43(1):140. SF1670, SB 202190, ApoA-IV Protein, Human (HEK293, His) purchased from MCE.

• J Exp Clin Cancer Res. 2024 May 3;43(1):133. Erastin, T0901317, Necrostatin-1, FINO2 purchased from MCE.

• J Adv Res. 2024 May 7:S2090-1232(24)00183-8. α-Linolenic acid, Taurine, Hypotaurine, Endothelin-1/EDN1 Protein, Rat (His-KSI) purchased from MCE.

• J Exp Clin Cancer Res. 2024 May 15;43(1):144. Enzalutamide, Phosphatase Inhibitor Cocktail I (100× in DMSO), Protease Inhibitor Cocktail (EDTA-Free, 100× in DMSO), Glia maturation factor beta/GMFB Protein, Human (His) purchased from MCE.

• J Adv Res. 2024 May 12:S2090-1232(24)00173-5. Honokiol, C646 purchased from MCE.

• J Adv Res. 2024 May 7:S2090-1232(24)00175-9. Rhod-2 AM purchased from MCE.

• J Adv Res. 2024 May 24:S2090-1232(24)00216-9. Erastin, Ferrostatin-1, Deferoxamine purchased from MCE.

• J Adv Res. 2024 Apr 30:S2090-1232(24)00172-3. Telaglenastat purchased from MCE.

• J Exp Clin Cancer Res. 2024 May 14;43(1):143. MG-132, Cycloheximide purchased from MCE.

• J Adv Res. 2024 May 8:S2090-1232(24)00184-X. Y-27632 dihydrochloride purchased from MCE.

• J Adv Res. 2024 Apr 27:S2090-1232(24)00171-1. Cell Counting Kit-8 purchased from MCE.

• J Adv Res. 2024 Apr 12:S2090-1232(24)00152-8. Tanshinone IIA sulfonate sodium purchased from MCE.

• J Exp Clin Cancer Res. 2024 Apr 4;43(1):105. SQ22536, Forskolin, H-89, Glycyrrhizic acid purchased from MCE.

• J Exp Clin Cancer Res. 2024 Apr 13;43(1):112. Erastin, IL-6 Protein, Mouse, MIP-1 alpha/CCL3 Protein, Mouse (His), MIG/CXCL9 Protein, Mouse (HEK293, His) purchased from MCE.

• J Exp Clin Cancer Res. 2024 Apr 16;43(1):115. Paclitaxel purchased from MCE.

• J Adv Res. 2024 Apr 26:S2090-1232(24)00167-X. Rotenone purchased from MCE.

• J Exp Clin Cancer Res. 2024 Apr 3;43(1):102. LXR-623 purchased from MCE.

• J Adv Res. 2024 Apr 10:S2090-1232(24)00131-0. Protein A/G Magnetic Beads purchased from MCE.

• J Adv Res. 2024 Mar 22:S2090-1232(24)00113-9. Kurarinone purchased from MCE.

• J Exp Clin Cancer Res. 2024 Mar 25;43(1):90. Ropivacaine hydrochloride purchased from MCE.

• J Exp Clin Cancer Res. 2024 Mar 12;43(1):76. RS 504393 purchased from MCE.

• J Exp Clin Cancer Res. 2024 Mar 5;43(1):68. Lactate (sodium) (60% in water), Phosphatase Inhibitor Cocktail I (100× in DMSO), ATG4C Protein, Human (His), Glia maturation factor beta/GMFB Protein, Human (His) purchased from MCE.

• J Exp Clin Cancer Res. 2024 Mar 12;43(1):77. Cisplatin purchased from MCE.

• J Adv Res. 2024 Mar 18:S2090-1232(24)00111-5. TBHQ, Diprovocim purchased from MCE.

• J Exp Clin Cancer Res. 2024 Mar 19;43(1):86. SX-682, Ladarixin, ASB13 Protein, Human (His) purchased from MCE.

• J Exp Clin Cancer Res. 2024 Mar 5;43(1):69. Birabresib, CPI-637 purchased from MCE.

• J Exp Clin Cancer Res. 2024 Feb 2;43(1):39. MG-132 purchased from MCE.

• J Exp Clin Cancer Res. 2024 Feb 21;43(1):52. Withaferin A, Actinomycin D, Cycloheximide purchased from MCE.

• J Exp Clin Cancer Res. 2024 Jan 2;43(1):7. MG-132, Cycloheximide purchased from MCE.

• J Exp Clin Cancer Res. 2024 Jan 11;43(1):18. Temsirolimus purchased from MCE.

• J Adv Res. 2024 Jan 12:S2090-1232(24)00025-0. 2-Deoxy-D-glucose, MG-132, Pifithrin-α hydrobromide, Cycloheximide purchased from MCE.

• J Adv Res. 2024 Jan 9:S2090-1232(24)00009-2. Cell Counting Kit-8 purchased from MCE.

• J Adv Res. 2024 Jan 12:S2090-1232(24)00007-9. Phosphatase Inhibitor Cocktail I (100× in DMSO), Glia maturation factor beta/GMFB Protein, Human (His) purchased from MCE.

• J Exp Clin Cancer Res. 2023 Dec 20;42(1):346. COH29 purchased from MCE.

• J Allergy Clin Immunol. 2023 Dec 8:S0091-6749(23)02411-9. Baricitinib, Y-27632 dihydrochloride, Tofacitinib purchased from MCE.

• J Exp Clin Cancer Res. 2023 Dec 5;42(1):330. Streptavidin Magnetic Beads purchased from MCE.

• J Exp Clin Cancer Res. 2023 Nov 23;42(1):315. Methyl-β-cyclodextrin purchased from MCE.

• J Exp Clin Cancer Res. 2023 Nov 6;42(1):294. Puromycin dihydrochloride purchased from MCE.

• J Exp Clin Cancer Res. 2023 Nov 4;42(1):292. Amivantamab purchased from MCE.

• J Exp Clin Cancer Res. 2023 Nov 25;42(1):316. Protein A/G Magnetic Beads purchased from MCE.

• J Adv Res. 2023 Oct 19:S2090-1232(23)00314-4. N,N-Dimethylsphingosine, D-erythro-MAPP purchased from MCE.

• J Exp Clin Cancer Res. 2023 Oct 27;42(1):284. Afatinib, Cell Counting Kit-8 purchased from MCE.

• J Exp Clin Cancer Res. 2023 Oct 3;42(1):258. Puromycin dihydrochloride, Galunisertib, Phosphatase Inhibitor Cocktail Ⅲ (100× in DMSO) , Protease Inhibitor Cocktail (EDTA-Free, 100× in DMSO) purchased from MCE.

• J Exp Clin Cancer Res. 2023 Oct 7;42(1):261. MG-132 purchased from MCE.

• J Adv Res. 2023 Oct 6:S2090-1232(23)00299-0. Y-33075 dihydrochloride, Y-27632 dihydrochloride, FGF-12 Protein, Human (177 a.a) purchased from MCE.

• J Exp Clin Cancer Res. 2023 Oct 7;42(1):260. Belinostat, Olaparib purchased from MCE.